Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heil Pharma is an India-based healthcare company focused on ophthalmic surgical products, viscoelastic and irrigation solutions, sodium hyaluronate injections, and related medical disposables. The business appears to operate as both a manufacturer and merchant exporter/distributor, with operations centered in Ahmedabad, Gujarat. Its marketed portfolio includes ophthalmic sodium hyaluronate solutions, hydroxypropyl methylcellulose ophthalmic solutions, disposable ophthalmic cannulas, surgical blades, drapes, fluorescein strips, and orthopedic sodium hyaluronate injections. Available sources indicate the company serves eye care and related healthcare markets rather than operating as a clinical-stage drug developer. The company seems to be commercially active and oriented toward product sales, manufacturing, and export.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heil Pharma.